Sunny Vitamin D3 – Multifaceted, Mysterious, Necessary

Cover Page

Cite item

Full Text

Abstract

The importance of vitamin D3 for maintaining the level of health in conditions of acute respiratory and vascular infectious pathology COVID-19 is considered. Physiological vitamin deficiency has been documented as a negative predictor of virus exposure and disease severity. A complex of clinical and experimental studies documents that vitamin D3 performs the function of controlling hemovascular homeostasis – the endothelium of the vascular wall, a complex of immunological reactions, coagulation and rheological properties of blood, systemic hemodynamics, etc. The variety of effects is determined by the transcriptional role of the vitamin D3 receptor, which expresses gene targets for synthesis functional protective proteins. The possibilities of supplementation, maintaining the level of vitamin D3 and its chemical metabolites, for the preventive and therapeutic strategy of COVID-19 are considered.

About the authors

O. A. Gomazkov

Orekhovich Research Institute of Biomedical Chemistry

Author for correspondence.
Email: oleg-gomazkov@yandex.ru
Russia, Moscow

References

  1. Геринг Х., Кожухова С. Витамин D – гормон солнца. А если солнца недостаточно? // Биохимия. 2015. Т. 80 (1). С. 14–28.
  2. Гомазков О.А. Эндотелий – мишень, которую выбирает коронавирус. М.: ИКАР, 2021. 62 с.
  3. Гомазков О.А. Постковидный синдром. Патофизиология системных дисрегуляций // Успехи соврем. биол. 2023. Т. 143 (3). С. 229–238.
  4. Ионова Ж.И., Сергеева Е.Г., Беркович О.А. Генетические и эпигенетические факторы, регулирующие экспрессию и функционирование рецептора витамина D у больных ишемической болезнью сердца // Рос. кардиол. журн. 2021. Т. 26 (1S). С. 425.
  5. Салухов В.В., Ковалевская Е.А. Витамин D – стратегический удар по коронавирусной инфекции // Мед. Совет. 2020. Т. 21. С. 218–228. https://doi.org/10.21518/2079-701X-2020-21-218-228
  6. Adams J.S., Ren S., Liu P.T. et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses // J. Immunol. 2009. V. 182. P. 4289–4295. https://doi.org/10.4049/jimmunol.0803736
  7. Ashique S., Gupta K., Gupta G. et al. Vitamin D – a prominent immunomodulator to prevent COVID-19 infection // Int. J. Rheum. Dis. 2023. V. 26 (1). P. 13–30. https://doi.org/10.1111/1756-185X.14477
  8. Argano C., Bocchio R.V., Natoli G. et al. Protective effect of vitamin D supplementation on COVID-19-related intensive care hospitalization and mortality: definitive evidence from meta-analysis and trial sequential analysis // Pharmaceuticals (Basel). 2023. V. 16 (1). P. 130. https://doi.org/10.3390/ph16010130
  9. Baeke F., Korf H., Overbergh L. et al. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system // J. Steroid. Biochem. Mol. Biol. 2010. V. 121 (1–2). P. 221–227.
  10. Barlow P.G., Svoboda P., Mackellar A. et al. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37 // PLoS One. 2011. V. 6. P. e25333. https://doi.org/10.1371/journal.pone.0025333
  11. Barrea L., Verde L., Grant W.B. et al. Vitamin D: a role also in long COVID-19? // Nutrients. 2022. V. 14 (8). P. 1625. https://doi.org/10.3390/nu14081625
  12. Ben-Eltriki M. Hopefl R., Wright J.M. et al. Association between vitamin D status and risk of developing severe COVID-19 infection: a meta-analysis of observational studies // J. Am. Nutr. Assoc. 2022. V. 41 (7). P. 679–689. https://doi.org/10.1080/07315724.2021.1951891
  13. Bouillon R. Vitamin D status in Africa is worse than in other continents // Lancet Glob. Heal. 2020. V. 8. P. e20–e21.
  14. Briceno Noriega D., Savelkoul H.F.J. Vitamin D: a potential mitigation tool for the endemic stage of the COVID-19 pandemic? // Front Publ. Health. 2022. V. 10. P. 888168. https://doi.org/10.3389/fpubh.2022.888168
  15. Capozzi A., Scambia G., Lello S. et al. Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health // Maturitas. 2020. V. 140. P. 55–63. https://doi.org/10.1016/j.maturitas.2020.05.020
  16. Castillo M.E., Costa L.M., Barrios J.M. et al. Effect of calcifediol treatment and best available therapy versus best available therapy patients hospitalized for COVID-19: a pilot randomized clinical study // J. Steroid Biochem. Mol. Biol. 2020. V. 203. P. 105751. https://doi.org/10.1016/j.jsbmb.2020.105751
  17. Carlberg C. Molecular endocrinology of vitamin D on the epigenome level // Mol. Cell. Endocrinol. 2017. V. 453. P. 14–21.
  18. Chakkera M., Ravi N., Ramaraju R. et al. The efficacy of vitamin D supplementation in patients with Alzheimer’s disease in preventing cognitive decline: a systematic review // Cureus. 2022. V. 14 (11). P. e31710. https://doi.org/10.7759/cureus.31710
  19. Charoenngam N., Jaroenlapnopparat A., Mettler S.K. et al. Genetic variations of the vitamin D metabolic pathway and COVID-19 susceptibility and severity: current understanding and existing evidence // Biomedicines. 2023. V. 11 (2). P. 400. https://doi.org/10.3390/biomedicines11020400
  20. Cicero A.F.G., Fogacci F., Borghi C. Vitamin D supplementation and COVID-19 outcomes: mounting evidence and fewer doubts // Nutrients. 2022. V. 14 (17). P. 3584. https://doi.org/10.3390/nu14173584
  21. Chiodini I., Davide Gatti D., Soranna D. et al. Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes // Front Publ. Health. 2021. V. 9. P. 736665. https://doi.org/10.3389/fpubh.2021.736665
  22. Dancer R.C.A., Parekh D., Lax S. et al. Vitamin D deficiency contributes directly to the acute respiratory distress syndrome // Thorax. 2015. V. 70. P. 617–624.
  23. Deluca H.F. History of the discovery of vitamin D and its active metabolites // Bonekey Rep. 2014. V. 3. P. 479. https://doi.org/10.1038/bonekey.2013.213
  24. Di Rosa M., Malaguarnera M., Nicoletti F. et al. Vitamin D3: a helpful immune-modulator // Immunology. 2011. V. 134 (2). P. 123–139. https://doi.org/10.1111/j.1365-2567.2011.03482.x
  25. Dissanayake H.A., de Silva N.L., Sumanatilleke M. et al. Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis // J. Clin. Endocrinol. Metab. // 2022. V. 107 (5). P. 1484–1502. https://doi.org/10.1210/clinem/dgab892
  26. Durmuş M.E., Kara O., Kara M. et al. The relationship between vitamin D deficiency and mortality in older adults before and during COVID-19 // Heart Lung. 2023. V. 57. P. 117–123. https://doi.org/10.1016/j.hrtlng.2022.09.007
  27. Gholi Z., Yadegarynia D., Eini-Zinab H. et al. Vitamin D deficiency is associated with increased risk of delirium and mortality among critically ill, elderly Covid-19 patients // Complement. Ther. Med. 2022. V. 70. P. 102855. https://doi.org/10.1016/j.ctim.2022.102855
  28. Gibson C., Davis C., Zhu W. et al. Dietary vitamin D and its metabolites non-genomically stabilize the endothelium // PLoS One. 2015. V. 10. P. e0140370. https://doi.org/10.1371/journal.pone.0140370
  29. Giménez V.M., Sanz R.L., Marón F.J.M. et al. Vitamin D: RAAS connection: an integrative standpoint into cardiovascular and neuroinflammatory disorders // Curr. Prot. Pept. Sci. 2020. V. 21. P. 948–954. https://doi.org/10.2174/1389203721666200606220719
  30. Glinsky G.V. Vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomics-guided tracing of SARS-CoV-2 targets in human cells // Biomedicines. 2020. V. 8 (5). P. 129. https://doi.org/10.3390/biomedicines8050129
  31. Göring H. Vitamin D in nature: a product of synthesis and/or degradation of cell membrane components // Biochemistry (Mosc.). 2018. V. 83 (11). P. 1350–1357.
  32. Han L., Xu X.J., Zhang J.S., Liu H.M. Association between vitamin D deficiency and levels of renin and angiotensin in essential hypertension // Int. J. Clin. Pract. 2022. Art. 8975396. https://doi.org/10.1155/2022/8975396
  33. Hansdottir S., Monick M.M., Lovanet N. et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state // J. Immunol. 2010. V. 184 (2). P. 965–974.
  34. Holick M.F. The one-hundred-year anniversary of the discovery of the sunshine vitamin D3: historical, personal experience and evidence-based perspectives // Nutrients. 2023. V. 15 (3). P. 593. https://doi.org/10.3390/nu15030593
  35. Hosseini B., El Abd A., Ducharme F. Effects of vitamin D supplementation on COVID-19 related outcomes: a systematic review and meta-analysis // Nutrients. 2022. V. 14. P. 2134. https://doi.org/10.3390/nu14102134
  36. Jablonski K.L., Chonchol M., Pierce G.L. et al. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults // Hypertension. 2011. V. 57. P. 63–69.
  37. Jenei T., Jenei S., T. Tamás L. et al. COVID-19 mortality is associated with low vitamin D levels in patients with risk factors and/or advanced age // Clin. Nutr. ESPEN. 2022. V. 47. P. 410–413. https://doi.org/10.1016/j.clnesp.2021.11.025
  38. Jude E.B., Ling S.F., Allcock R. et al. Vitamin D deficiency is associated with higher hospitalization risk from COVID-19 // J. Clin. Endocrinol. Metab. 2021. V. 106 (11). P. e4708–e4715. /https://doi.org/10.1210/clinem/dgab439
  39. Khojah H.M.J., Ahmed S.A., Al-Thagfan S.S. et al. The impact of serum levels of vitamin D3 and its metabolites on the prognosis and disease severity of COVID-19 // Nutrients. 2022. V. 14 (24). P. 5329. https://doi.org/10.3390/nu14245329
  40. Kong J., Zhu X., Shi Y. et al. VDR attenuates acute lung injury by blocking Ang-2–Tie-2 pathway and rennin-angiotensin system // Mol. Endocrinol. 2013. V. 27. P. 2116–2125.
  41. Li Y.C., Kong J., Wei M. et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system // J. Clin. Invest. 2002. V. 110. P. 229–238.
  42. Lin R., White J.H. The pleiotropic actions of vitamin D // BioEssays. 2004. V. 26. P. 21–28.
  43. Lin L., Zhang L., Li Ch. et al. Vitamin D and vitamin D receptor: new insights in the treatment of hypertension // Curr. Prot. Pept. Sci. 2019. V. 20 (10). P. 984–995. https://doi.org/10.2174/1389203720666190807130504
  44. Liu P.T., Stenger S., Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response // Science. 2006. V. 311. P. 1770–1773. https://doi.org/10.1126/science.1123933
  45. Malek Mahdavi A. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: implications for a potential treatment for COVID-19 // Rev. Med. Virol. 2020. V. 30 (5). P. e2119.
  46. McCollum E.V., Davis M. The necessity of certain lipins in the diet during growth // J. Biol. Chem. 1913. V. 15. P. 167–175.
  47. Oz F., Cizgici AY., Oflaz H. et al. Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function // Coron. Artery Dis. 2013. V. 24 (5). P. 392–397. https://doi.org/10.1097/MCA.0b013e328362b2c8
  48. Pál É., Ungvári Z., Benyó Z., Várbíró S. Role of vitamin D deficiency in the pathogenesis of cardiovascular and cerebrovascular diseases // Nutrients. 2023. V. 15 (2). P. 334. https://doi.org/10.3390/nu15020334
  49. Pilz S., Verheyen N., Grübler M.R. et al. Vitamin D and cardiovascular disease prevention // Nat. Rev. Cardiol. 2016. V. 13 (7). P. 404–417. https://doi.org/10.1038/nrcardio.2016.73
  50. Quesada-Gomez J.M., Lopez-Miranda J., Entrenas-Castillo M. et al. Vitamin D endocrine system and COVID-19: treatment with calcifediol // Nutrients. 2022. V. 14 (13). P. 2716. https://doi.org/10.3390/nu14132716
  51. Renke G., Starling-Soares B., Thomaz Baesso T. et al. Effects of vitamin D on cardiovascular risk and oxidative stress // Nutrients. 2023. V. 15 (3). P. 769. https://doi.org/10.3390/nu15030769
  52. Shah K., Varna V.P., Sharma U. et al. Does vitamin D supplementation reduce COVID-19 severity?: a systematic review // QJM. 2022. V. 115 (10). P. 665–672. https://doi.org/10.1093/qjmed/hcac040
  53. Simpson R.U., Hershey S.H., Nibbelink K.A. Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse // J. Steroid. Biochem. 2007. Mol. Biol. V. 103. P. 521–24. https://doi.org/10.1016/j.jsbmb.2006.12.098
  54. Soltani-Zangbar M.S., Mahmoodpoor A., Dolati S. et al. Serum levels of vitamin D and immune system function in patients with COVID-19 admitted to intensive care unit // Gene Rep. 2022. V. 26. P. 101509.https://doi.org/10.1016/j.genrep.2022.101509
  55. Tang J. COVID-19 Pandemic and osteoporosis in elderly patients // Aging Dis. 2022. V. 13. P. 960–969.
  56. Thickett D.R., Moromizato T., Litonjua A.A. et al. Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study // BMJ Open Respir. Res. 2015. V. 2. P. 1–8. https://doi.org/10.1136/bmjresp-2014-000074
  57. Tishkoff D.X., Nibbelink K.A., Holmberg K.H. et al. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility // Endocrinology. 2008. V. 149. P. 558–564.
  58. White J.H. Emerging roles of vitamin D-induced antimicrobial peptides in antiviral innate immunity // Nutrients. 2022. V. 14 (2). P. 284. https://doi.org/10.3390/nu14020284
  59. Wong M.S., Delansorne R., Man R.Y. et al. Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat // Am. J. Physiol. Heart Circ. Physiol. 2008. V. 295. P. H289–H296.
  60. Xu Y., Baylink D.J., Chen C.-S. et al. The importance of vitamin D metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19 // J. Transl. Med. 2020. V. 18 (1). P. 322. https://doi.org/10.1186/s12967-020-02488-5

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2.

Download (288KB)
Indexing metadata
3.

Download (666KB)
Indexing metadata
4.

Download (268KB)
Indexing metadata

Copyright (c) 2023 Russian Academy of Sciences